To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
Jeong Jin-hyeok
Advertisement
Jeong Jin-hyeok is principal scientist in drug product at Samsung Biologics.
Articles by Jeong Jin-hyeok
Advertisement
Latest Updated Articles
Preparing for a New Wave of mRNA TechnologiesMay 15th 2023
Advertisement
Advertisement
Trending on BioPharm International
1
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
2
AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform
3
J&J’s Dual-Antigen Bispecific Regimen Achieves 73% PSA Response in Advanced Prostate Cancer
4
argenx Agrees to Buy Unnatural Products in Up to $1.15 Billion Deal
5